Table 3.
Significant differences in signs and symptoms for cases coinfected with MPX and VZV compared with patients with MPX or VZV alone, controlling for age.
| Signs/symptom comparison* | Frequencies, % | Chi-square |
|---|---|---|
| Coinfection vs. MPX | P-value | |
| ↓ Bed ridden | 18.0 vs. 29.0 | 0.02 |
| ↓ Cough | 46.2 vs. 58.6 | 0.02 |
| ↓ Mouth sores | 41.5 vs. 58.7 | 0.001 |
| ↓ Sore throat | 57.8 vs. 76.0 | 0.0002 |
| ↓ Axillary lymphadenopathy | 43.6 vs. 58.2 | 0.006 |
| Coinfection vs. VZV | P-value | |
|---|---|---|
| ↑ Bed ridden | 18.0 vs. 10.5 | 0.03 |
| ↑ Conjunctivitis | 22.4 vs 11.8 | 0.004 |
| ↑ Fatigue | 86.1 vs. 76.1 | 0.02 |
MPX = monkeypox; VZV = varicella zoster virus. Cases from surveillance dataset from September 2009 to April 2014. Based on 980 cases and classified as MPX, VZV, or MPX/VZV coinfections.
*
Less than comparator (↓) greater than comparator (↑).